Nihon Kohden Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3706800004
JPY
1,434.50
-108 (-7.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.45 M

Shareholding (Jun 2017)

FII

0.74%

Held by 1 FIIs

DII

99.26%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a 3.71% CAGR growth in Net Sales over the last 5 years

 
2

Poor long term growth as Net Sales has grown by an annual rate of 3.71% over the last 5 years

 
3

Flat results in Mar 26

4

With ROE of 8.32%, it has a fair valuation with a 1.35 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 263,880 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

9.26%

stock-summary
Price to Book

1.47

Revenue and Profits:
Net Sales:
47,405 Million
(Quarterly Results - Jun 2026)
Net Profit:
-756 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.1%
0%
0.1%
6 Months
-13.24%
0%
-13.24%
1 Year
-12.05%
0%
-12.05%
2 Years
-19.27%
0%
-19.27%
3 Years
-61.34%
0%
-61.34%
4 Years
-53.5%
0%
-53.5%
5 Years
-58.78%
0%
-58.78%

Nihon Kohden Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.71%
EBIT Growth (5y)
-3.54%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
1.18
Tax Ratio
26.90%
Dividend Payout Ratio
35.85%
Pledged Shares
0
Institutional Holding
0.74%
ROCE (avg)
17.81%
ROE (avg)
11.13%

Valuation key factors

Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.35
EV to EBIT
11.28
EV to EBITDA
8.97
EV to Capital Employed
1.39
EV to Sales
0.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.30%
ROE (Latest)
8.32%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2017stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.74%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -5.23% vs 8.21% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -489.69% vs -74.67% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47,405.00",
          "val2": "50,020.00",
          "chgp": "-5.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "610.00",
          "val2": "2,483.00",
          "chgp": "-75.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "114.00",
          "val2": "107.00",
          "chgp": "6.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-74.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-756.00",
          "val2": "194.00",
          "chgp": "-489.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20.60%",
          "val2": "28.40%",
          "chgp": "-4.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 4.29% vs 1.55% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 3.35% vs -17.20% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "235,099.00",
          "val2": "225,424.00",
          "chgp": "4.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24,604.00",
          "val2": "24,904.00",
          "chgp": "-1.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "341.00",
          "val2": "144.00",
          "chgp": "136.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3,241.00",
          "val2": "-834.00",
          "chgp": "-288.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14,570.00",
          "val2": "14,098.00",
          "chgp": "3.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "79.90%",
          "val2": "91.90%",
          "chgp": "-1.20%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
47,405.00
50,020.00
-5.23%
Operating Profit (PBDIT) excl Other Income
610.00
2,483.00
-75.43%
Interest
114.00
107.00
6.54%
Exceptional Items
0.00
-74.00
100.00%
Consolidate Net Profit
-756.00
194.00
-489.69%
Operating Profit Margin (Excl OI)
-20.60%
28.40%
-4.90%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2026 is -5.23% vs 8.21% in Jun 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is -489.69% vs -74.67% in Jun 2025

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
235,099.00
225,424.00
4.29%
Operating Profit (PBDIT) excl Other Income
24,604.00
24,904.00
-1.20%
Interest
341.00
144.00
136.81%
Exceptional Items
-3,241.00
-834.00
-288.61%
Consolidate Net Profit
14,570.00
14,098.00
3.35%
Operating Profit Margin (Excl OI)
79.90%
91.90%
-1.20%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 4.29% vs 1.55% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 3.35% vs -17.20% in Mar 2025

stock-summaryCompany CV
About Nihon Kohden Corp. stock-summary
stock-summary
Nihon Kohden Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available